BioCorRx BICX
OTC BICX
$0.25 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

BioCorRx (BICX) Non-Current Debt (2010 - 2026)

Updated

BioCorRx (BICX) reported Non-Current Debt of -$28,000 for FY2015, compared with -$131,296 in FY2014.

Analysis

BioCorRx (BICX) Non-Current Debt (2010 - 2026) Analysis & Trends

Dating back to FY2012, BioCorRx's Non-Current Debt record includes 4 years.

  • According to Business Quant data, Non-Current Debt came in at -$131,296 in FY2014, -$57,253 in FY2013 and -$47,077 in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 37.34 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 62.48 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 23.68 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 23.83 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 60.50 Bn
10 BioCorRx 4.32 Mn 3.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 69,155.00
Dec 31, 2025 69,537.00
Sep 30, 2025 69,803.00
Jun 30, 2025 500,000.00
Mar 31, 2025 500,000.00
Dec 31, 2024 71,029.00
Sep 30, 2024 500,000.00
Jun 30, 2024 146,426.00
Mar 31, 2024 146,426.00
Dec 31, 2023 606,750.00
Sep 30, 2023 408,238.00
Jun 30, 2023 359,729.00
Mar 31, 2023 350,418.00
Dec 31, 2022 297,602.00
Sep 30, 2022 500,000.00
Jun 30, 2022 500,000.00
Mar 31, 2022 500,000.00
Dec 31, 2021 221,480.00
Dec 31, 2020 21,480.00
Jun 30, 2020 290,110.00
API Access

BioCorRx Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=BICX&period=max&api_key=YOUR_API_KEY